BIOCYTOGEN-B
0231550.1504.13% ( +1.990 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BIOCYTOGEN-B(02315) the Revenue is 490.97 M (+83.86%);the EBIT is 151.84 M (+1192%);the EPS is 0.261 (+911.6%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.49B83.86%
----
----
EBIT
0.15B1191.66%
----
----
EPS
0.2608911.60%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf